...
首页> 外文期刊>Lab on a chip >Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells
【24h】

Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells

机译:肿瘤抗原无关和细胞大小变异 - 可行性循环肿瘤细胞的可包容性富集

获取原文
获取原文并翻译 | 示例
           

摘要

Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of metastatic cancer. The roles and clinical values of CTCs are under intensive investigation, yet most studies are limited by technical challenges in the comprehensive enrichment of intact and viable CTCs with minimal white blood cell (WBC) contamination. Here, we report a novel method based on contrast of cell magnetization in biocompatible ferrofluids (a colloidal magnetic nanoparticle suspension), termed as integrated ferrohydrodynamic cell separation (iFCS), that enriches CTCs in a tumor antigen-independent and cell size variation-inclusive manner, achieves a high throughput (12 mL h(-1)), high recovery rate (99.08% at down to similar to 10 cells per mL spike ratio), and low WBC contamination (533 cells for every one milliliter blood processed) and is biocompatible. This method will enable large cohort research to define the clinical and diagnostic value of CTC subtypes.
机译:血液中循环肿瘤细胞(CTC)的分离为转移性癌症的基本理解,诊断和预后提供了微创替代品。 CTCS的作用和临床价值在密集调查中,大多数研究受到在最小的白细胞(WBC)污染的完整和可行性CTC的综合性和活性CTC中的技术挑战的限制。在这里,我们报告了一种基于生物相容性铁物磁性流体(胶体磁性纳米粒子悬浮液)中细胞磁化的对比的新方法,称为集成的厌氧动力学细胞分离(IFCs),其在肿瘤抗原无关和细胞尺寸变异 - 包容性的肿瘤中富集CTC ,达到高通量(12mL H(-1)),高回收率(下降至相似的99.08%至每mL峰值比例),以及低WBC污染(每一个毫升血液处理的533个细胞),是生物相容性。该方法将使大型队列研究能够定义CTC亚型的临床和诊断值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号